Malaria remains a world's disease burden causing high incidences of mortality in susceptible populations.Severe cases of malaria are caused by parasites of the apicomplexan Plasmodium falciparum localized in sub-saharan Africa whereas less severe malaria but most prevalent outside Africa is caused by Plasmodium vivax.Malaria campaigns through vector control and effective artemesinins-based combination therapy has considerably reduced malarial mortality ratesin the past decade.However, increasing cases of drug resistance has raised an urgent need for development of new anti-malarial drugs. In-silico drug design using the structure of the biological target is the latest lead optimization option in search of more potent drugs.In this work, i sought to determine the 3-dimensional structure of the biological target,dehydroorotate dihydrogenase(DHODH) from the above mentioned plasmodia species co-crystallized with novel drug candidates.Characterization of the parasitic DHODH involved target... Это и многое другое вы найдете в книге Characterization of dihydroorotate dehydrogenase for malaria therapy (Leah Kago,Rhawnie Caing-Carlsson and Rosmarie Friemann)